Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules

  1. ZhiChao Wang*,
  2. Myoung Kwon Choi*,
  3. Tatsuma Ban*,
  4. Hideyuki Yanai*,
  5. Hideo Negishi*,
  6. Yan Lu*,
  7. Tomohiko Tamura*,
  8. Akinori Takaoka*,,
  9. Kazuko Nishikura, and
  10. Tadatsugu Taniguchi*,§
  1. *Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan; and
  2. The Wistar Institute, Philadelphia, PA 19104
  1. Contributed by Tadatsugu Taniguchi, February 12, 2008 (received for review January 30, 2008)

Abstract

DNA, whether it is microbe-derived or host-derived, evokes immune responses when exposed to the cytosol of a cell. We previously reported that DNA-dependent activator of IFN regulatory factors (DAI), also referred to as DLM-1/ZBP1, functions as a DNA sensor that activates the innate immune system. In the present study, we examined the regulation of the complex DNA-sensing system by DAI and other molecules. We first show that DAI directly interacts with DNA in vitro and that it requires three DNA-binding domains for full activation in vivo. We also show that the artificially induced dimerization of DAI results in the DNA-independent activation of type I IFN genes, thereby providing a better understanding for the molecular basis of DAI activation. Furthermore, we provide evidence for the presence of additional DNA sensors, either positively or negatively regulating cytosolic DNA-mediated innate immune responses. These results in toto provide insights into the mechanism of DAI activation and reveal the complex regulatory mechanisms underlying DNA-mediated protective and pathologic immune responses.

Footnotes

  • §To whom correspondence should be addressed. E-mail: tada{at}m.u-tokyo.ac.jp
  • Author contributions: Z.W., M.K.C., and T.B. contributed equally to this work; H.N., T. Tamura, A.T., and T. Taniguchi designed research; Z.W., M.K.C., T.B., H.Y., and Y.L. performed research; Z.W., M.K.C., T.B., H.Y., T. Tamura, and K.N. analyzed data; and Z.W., M.K.C., T.B., H.Y., T. Tamura, K.N., and T. Taniguchi wrote the paper.

  • Present address: Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0808, Japan.

  • The authors declare no conflict of interest.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0801295105/DCSupplemental.

« Previous | Next Article »Table of Contents